AmerisourceBergen Corporation (ABC)
ABC Price and Sentiment
ABC Latest news
In this article series, we provide a weekly summary of dividend changes. A summary table presents relevant data and key statistics of dividend increases.
AmerisourceBergen to Now Offer Prime Therapeutics' IntegratedRx™ – Oncology to Eligible Hospital, Health System & Oncology Practice Customers2021-11-10 08:30
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen, a global healthcare company and a leader in supporting specialty pharmaceuticals through distribution, commercialization, and provider access and solutions, today announced that it is now offering Prime Therapeutics' IntegratedRx™ – Oncology program to eligible hospital, health system and independent oncology practice customers. Prime Therapeutics (Prime) is a pharmacy benefit manager (PBM) serving more than 33 million members. Through medi
AmerisourceBergen (ABC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
3 Reasons AmerisourceBergen Is A SWAN Worth Buying Today
AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q4 Fiscal 2021 Results - Earnings Call Transcript2021-11-04 11:59
AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q4 Fiscal 2021 Results - Earnings Call Transcript
AmerisourceBergen (ABC) delivered earnings and revenue surprises of 1.27% and 3.92%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
AmerisourceBergen's (ABC) fiscal fourth-quarter results benefit from segmental growth.
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2021 fourth quarter ended September 30, 2021, revenue increased 19.6 percent to $58.9 billion. Revenue increased 12.7 percent to $214.0 billion for the fiscal year. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $2.08 for the September quarter of fiscal 2021, compared to $(23.74) in the prior year quarter. Adjusted dilute
AmerisourceBergen Corp. ABC, +2.47% reported Thursday that it swung to a fiscal fourth-quarter profit, as the drug distribution company moved past expenses related to opioid lawsuits, and revenue that rose above expectations. Net income for the quarter to Sept.
AmerisourceBergen's (ABC) fiscal fourth-quarter results are likely to reflect solid performance at Pharmaceutical Distribution and Other units.